MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. - Wikidata - wikimedia - TriplyDB

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

http://www.wikidata.org/entity/Q39176725

about

Claudin 1 in Breast Cancer: New Insights Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy MicroRNA-155 expression is independently predictive of outcome in chordoma.Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3.RNA-seq analysis revealed novel genes and signaling pathway associated with disease resistance to avian influenza virus infection in chickens.Enterovirus 71 induces apoptosis of SH‑SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression.Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells.Quercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells.microRNA-182 inhibits the proliferation and migration of glioma cells through the induction of neuritin expression Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2.MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.LIN28B suppresses microRNA let-7b expression to promote CD44+/LIN28B+ human pancreatic cancer stem cell proliferation and invasion Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation Tight junction proteins: from barrier to tumorigenesis.Emerging roles of claudins in human cancer microRNAs in nociceptive circuits as predictors of future clinical applications.Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by suppressing miR-155 expression and activating FBXW7 function.MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP.The pivotal role of microRNA-155 in the control of cancer.MicroRNAs: New therapeutic targets for intestinal barrier dysfunction.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.MicroRNAs regulate tight junction proteins and modulate epithelial/endothelial barrier functions.microRNA and Ovarian Cancer.miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway.MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1.MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins.The role of claudins in cancer metastasis.Claudins in cancer: bench to bedside.Comparative aspects of MicroRNA Expression in Canine and Human Cancer.MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway.Disruption of Claudin-1 Expression by miRNA-182 Alters the Susceptibility to Viral Infectivity in HCV Cell Models.EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway.miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells.MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells.Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer.

P2860

Q26774988-15633814-827E-430A-A8DB-B7442F7A3905 Q26787279-C49C2946-C1B7-4816-96DF-AD5379937603 Q26851347-FE5B1955-BF15-4B02-98BE-CBFE7D9EBFC4 Q33275600-BA62AF0E-FAE5-41D3-A62E-BBF657C40482 Q33838977-40FADF73-B1A3-46A7-ADAE-1B9BCE88DFE2 Q33914216-FF4ACAA3-CF1D-4CCD-B8F6-62D4112C5D3F Q34389043-71ADDCEB-57DB-4ABA-BA03-97E1F6828BC1 Q35103091-B85AE1F4-C655-4C7E-AF5A-891DBA1BABC7 Q35628398-7C6BEDB2-ABC5-4FFC-8D6F-AE034291F084 Q35808662-20C4A1E9-A18A-47A9-8964-12C7DC4E7C0A Q35808952-57E13DCE-0631-46E2-89DC-91F1A279615A Q35870231-E9E4E506-4C63-4A21-864B-47DB1A94AE7F Q35959329-7600AE36-76D3-4B7F-A97E-B84C4966CF4E Q36140715-4332CD1E-876C-42D6-8F41-591FDA1636B4 Q36250610-BD4F4A7C-FC95-4FBF-A1C8-A68A093548FA Q36413501-969CADCF-F17D-420D-8B55-004DBAF5DA4A Q37059796-DECCCD35-A82E-45C0-9BBC-57B75D6D8CCE Q37086079-6A149731-A61A-4DD2-80EE-8F9AD7AA3EB0 Q37118065-C3862EBD-4623-46D5-9383-DC27AF9C5D80 Q37225107-7848A796-31CB-466C-9CAA-58FCA9C9754B Q37233099-539122D4-142F-46E4-9672-AB303EE533EF Q37447899-9A471BB3-3027-4F35-9C38-32ECCCB729A5 Q37729740-AC9783C4-698F-42D5-B6F7-923B38A3589C Q38152297-2E27D43E-00FB-4D64-83A6-C59ABB9CDF28 Q38219024-6B91DEC4-4538-4775-B458-51A125A00B84 Q38258014-767F89B8-CAB8-46C1-BBC2-0C2817EBD211 Q38328002-85B87BED-2557-466A-8987-9700CF2837AB Q38667018-0BEBA422-F19E-4F31-A27A-040A1CACE680 Q38705370-E1C09B52-47ED-413F-B74F-2A43649BDF76 Q38787890-6001E020-B5C9-4958-9897-977AF50F03A5 Q38926686-D68AE581-12E9-4804-9856-7C127B876381 Q38927656-1AC804FC-4A79-4EC5-9F53-450D033A41C3 Q38953546-494A34F9-5696-4BB2-9FB2-BCFA208982C6 Q46304395-24F261A1-9B37-407D-9CA9-B76A739F7CCA Q51503055-610E762E-1558-4165-AC9E-0A637A9726CC Q52332712-3300511A-9DD5-4968-A585-FD6C70ED7D5F Q53055131-69573013-BD42-4814-A7E2-7AE10E12BC04 Q53125127-8599867C-FE11-4040-A017-87773C4AFB47 Q53205827-CC6071C3-9B6F-46DF-8D3C-DBA924390492 Q54195692-EFC3797E-7652-45C9-9DAF-BF67C8B7902B

P2860

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

http://www.wikidata.org/entity/Q39176725

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

@en

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

@nl

type

label

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

@en

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

@nl

prefLabel

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

@en

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

@nl

P1433

Q39176725-17803684-A4FA-4F73-A7FC-7597CB0AC635

P1476

Q39176725-C88A5A49-B487-4BA7-925A-8BB520E0B47F

P2093

Q39176725-25CDAE4B-77EC-4D2F-B382-71F0EB0E2337

Q39176725-35509BAD-8834-4615-8226-BFCF0A0A50A8

Q39176725-3A4A084F-827D-4108-B1E4-E71830CC8F2A

Q39176725-7698FDDA-E856-4E5D-8B0E-6709B8E3FE6D

Q39176725-F05533B9-F385-487F-B021-F65AA53CA178

P2860

Q39176725-253E4417-32F7-48CB-B4E5-14E3BDEA13E3

Q39176725-412833F0-0E5A-465C-A434-2E866CC1C99C

Q39176725-4154E734-89F2-44DF-B47B-309FEA39D26E

Q39176725-46EB536B-7DC7-4BBE-8F1B-EBFAD00EF22F

Q39176725-560C7A0F-8B5E-4EAB-A421-ABDD6C3FACD5

Q39176725-57E7780F-B586-4CBF-8A34-5A2645F1545E

Q39176725-5D77BF98-D350-4E62-96E8-D6F986C80767

Q39176725-8D40C3EF-F246-4BF0-9477-546E8E8B9FC9

Q39176725-8F6B5144-DBBA-4D7A-BE2E-35C9244AEA4C

Q39176725-9382A18F-0EA1-448E-A513-2BE31611BC78

P304

Q39176725-74EBA5D0-01AB-4E4C-AA90-C4E828118804

P31

Q39176725-1BA2F0C6-E19E-4DA4-B4E6-4EFA7D555271

P356

Q39176725-D03C214C-FC6E-4E7F-A76A-E570EE12B6D6

P407

Q39176725-5C5D19AF-3558-4F60-9D1C-1A2254044335

P433

Q39176725-2EA2A9A3-712D-474F-ADFD-37FE57F32DAF

P478

Q39176725-ED02DB75-2746-4B03-904D-0630BA7C8C68

P577

Q39176725-92515797-7A44-411E-B5A0-F7496160ECD1

P5875

Q39176725-30FFE870-5B93-4A2A-A46D-B3412392BCE4

P698

Q39176725-A8A50C3F-4455-41C3-9D5C-C6029C235EFC

P921

Q39176725-989E34F5-A996-4719-BDF6-E51D90DD6869

Q39176725-9C1CD642-B81A-40B6-85E8-6D67D49B6FC0

P356

J.FEBSLET.2013.03.023

P1433

P1476

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

@en

P2093

Jiejun Wang

http://www.w3.org/2001/XMLSchema#string

Qiusheng Ren

http://www.w3.org/2001/XMLSchema#string

Te Liu

http://www.w3.org/2001/XMLSchema#string

Wenxing Qin

http://www.w3.org/2001/XMLSchema#string

Yongyi Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

Inositol phosphatase SHIP1 is a primary target of miR-155

Shhh! Silencing by microRNA-155

Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes

DNA methylation and microRNA dysregulation in cancer

Anti-apoptotic effect of claudin-1 in tamoxifen-treated human breast cancer MCF-7 cells

MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.

Caudal homeobox protein Cdx-2 cooperates with Wnt pathway to regulate claudin-1 expression in colon cancer cells.

P304

1434-1439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FEBSLET.2013.03.023

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

587

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236075718

http://www.w3.org/2001/XMLSchema#string

P698

23523916

http://www.w3.org/2001/XMLSchema#string

P921